Showing 2 of 2 recruiting trials for “Rare neoplastic disease”
RecruitingNCT07147465 ↗
Performance Indicators and Impact on the Care Pathway of Sequencing on the SeqOIA and AURAGEN (Seqogen) Platforms for Oncology Patients
👨⚕️ Isabelle DURAND-ZALESKI, Professor, Greater Paris University Hospitals📍 3 sites📅 Started Jul 2025View details ↗
PLATFORM Study of Precision Medicine for Rare Tumors
👨⚕️ Ning Li, Doctor, Cancer Institute and Hospital, Chinese Academy of Medical Sciences📍 1 site📅 Started Aug 2020View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →